$XORTX Therapeutics Inc.(XRTX)_老虎社区_美港股上老虎

2023-01-20

$XORTX Therapeutics Inc.(XRTX)$ There’s great news circulating about Xortx Therapeutics (NASDAQ:XRTX) today. In a clinical study, XORLO, Xortx’s orally administered brand of oxypurinol, demonstrated a “substantial increase” in bioavailability. This news caused a huge spike in XRTX stock this morning, though it has since lost some momentum.

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":626239245,"tweetId":"626239245","gmtCreate":1674198328088,"gmtModify":1674198329583,"author":{"id":9000000000000416,"idStr":"9000000000000416","authorId":9000000000000416,"authorIdStr":"9000000000000416","name":"RachelEuphemia","avatar":"https://static.tigerbbs.com/b1fa5d9ceb6a8fc80f198e797e2994a9","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/XRTX\">$XORTX Therapeutics Inc.(XRTX)$</a> &nbsp;There’s great news circulating about Xortx Therapeutics (NASDAQ:XRTX) today. In a clinical study, XORLO, Xortx’s orally administered brand of oxypurinol, demonstrated a “substantial increase” in bioavailability. This news caused a huge spike in XRTX stock this morning, though it has since lost some momentum.</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/XRTX\">$XORTX Therapeutics Inc.(XRTX)$</a> &nbsp;There’s great news circulating about Xortx Therapeutics (NASDAQ:XRTX) today. In a clinical study, XORLO, Xortx’s orally administered brand of oxypurinol, demonstrated a “substantial increase” in bioavailability. This news caused a huge spike in XRTX stock this morning, though it has since lost some momentum.</p></body></html>","text":"$XORTX Therapeutics Inc.(XRTX)$ There’s great news circulating about Xortx Therapeutics (NASDAQ:XRTX) today. In a clinical study, XORLO, Xortx’s orally administered brand of oxypurinol, demonstrated a “substantial increase” in bioavailability. This news caused a huge spike in XRTX stock this morning, though it has since lost some momentum.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/626239245","repostId":0,"isVote":1,"tweetType":1,"viewCount":713,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["XRTX"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":295,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/626239245"}